The company made this announcement after market hours of Friday, 30 December 2011.

Meanwhile, the BSE Sensex was up 72.74 points, or 0.47% to 15,527.66.

On BSE, 8.76 lakh shares were traded in the counter as against average daily volume of 4.58 lakh shares in the past one quarter.

The stock hit a high of Rs 136.55 and a low of Rs 124.30 so far during the day. The stock had hit a 52-week low of Rs 112.25 on 19 December 2011. The stock had hit a 52-week high of Rs 324.65 on 4 April 2011.

The stock underperformed the market over the past one month till 30 December 2011, falling 16.96% compared with the Sensex's 4.15% fall. The scrip had also underperformed the market in past one quarter, declining 19.89% as against 6.07% decline in the Sensex.

The small-cap pharmaceutical company has an equity capital of Rs 70.44 crore. Face value per share is Rs 10.

On a consolidated basis, Orchid Chemicals & Pharmaceuticals' net profit rose 19.6% to Rs 20.73 crore on 17.8% growth in net sales to Rs 458.75 crore in Q2 September 2011 over Q2 September 2010.

Orchid Chemicals & Pharmaceuticals is a leading pharmaceutical company headquartered in Chennai. The company is involved in the development, manufacture and marketing of diverse bulk activities, formulations and nutraceuticals.